Impact of Hematopoietic Stem Cell Transplantation on PD-1 Blockade Efficacy in Relapsed/Refractory Hodgkin’s Lymphoma
Background: Classical Hodgkin lymphoma (cHL) is a treatable malignancy; however, relapsed or refractory (R/R) cases pose significant challenges. PD-1 inhibitors have shown efficacy, but the role of hematopoietic stem cell transplantation (HSCT) following PD-1 blockade remains uncertain. This study a...
Saved in:
Main Authors: | Filomena Emanuela Laddaga, Pierluigi Masciopinto, Valentina Bozzoli, Domenico Pastore, Vincenzo Pavone, Angelo Michele Carella, Nicola Di Renzo, Attilio Guarini, Pellegrino Musto, Francesco Gaudio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-04-01
|
Series: | Transplantology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-3943/6/2/12 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor‐associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma
by: Maja Dam Andersen, et al.
Published: (2025-07-01) -
Observations on seasonal occurrence in lymphomas with proven or presumed infectious etiology
by: Ioannis Anagnostopoulos, et al.
Published: (2025-07-01) -
Refractory/Relapsed Classic Hodgkin Lymphoma Mimicking Disseminated Tuberculosis
by: Mohamed Nazem Alibrahim, et al.
Published: (2025-05-01) -
Nivolumab for relapsed and refractory classical Hodgkin lymphoma: retrospective single center analysis
by: Magdalena Witkowska, et al.
Published: (2025-01-01) -
Treatment outcomes and survival analysis of pediatric mature B-Cell non-Hodgkin lymphoma: A retrospective study comparing LMB96 and R-CHOP regimens
by: Hamid D. Habeeb Rjeib, et al.
Published: (2025-01-01)